Singapore markets close in 4 hours 11 minutes
Straits Times Index
3,301.53 +8.84 (+0.27%) Nikkei
38,248.58 -25.47 (-0.07%) Hang Seng
18,155.28 +392.25 (+2.21%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,418.36 -2,763.73 (-4.59%) CMC Crypto 200
1,263.36 -75.70 (-5.65%)
Vincerx Pharma, Inc. (VINC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 20.82M |
| Enterprise value | 10.54M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.86 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.25 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.81 |
| 52-week change 3 | -45.12% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 9.3720 |
| 52-week low 3 | 0.6100 |
| 50-day moving average 3 | 3.9234 |
| 200-day moving average 3 | 1.7210 |
Share statistics
| Avg vol (3-month) 3 | 1.22M |
| Avg vol (10-day) 3 | 576.16k |
| Shares outstanding 5 | 23.53M |
| Implied shares outstanding 6 | 29.53M |
| Float 8 | 18.66M |
| % held by insiders 1 | 19.69% |
| % held by institutions 1 | 31.92% |
| Shares short (15 Apr 2024) 4 | 1.2M |
| Short ratio (15 Apr 2024) 4 | 0.72 |
| Short % of float (15 Apr 2024) 4 | 7.93% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.59% |
| Shares short (prior month 15 Mar 2024) 4 | 863.7k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -68.72% |
| Return on equity (ttm) | -136.38% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -42.56M |
| Net income avi to common (ttm) | -40.16M |
| Diluted EPS (ttm) | -1.8900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 12.78M |
| Total cash per share (mrq) | 0.6 |
| Total debt (mrq) | 2.5M |
| Total debt/equity (mrq) | 22.29% |
| Current ratio (mrq) | 2.63 |
| Book value per share (mrq) | 0.52 |
Cash flow statement
| Operating cash flow (ttm) | -40.45M |
| Levered free cash flow (ttm) | -24.29M |
© 2024 Yahoo. All rights reserved.